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Introduction
In a variety of conditions excessive and/or persistent
activation of the innate immune system has detrimental
effects. In animals, electrical vagus nerve stimulation
(VNS) inhibits the innate immune response in models
of endotoxemia (administration of lipopolysaccharide
[LPS]), sepsis, trauma, and hemorrhagic shock, via the
so-called cholinergic anti-inflammatory pathway. How-
ever, human in vivo evidence is lacking. Up till now,
VNS was possible through implantation of a cuff elec-
trode wrapped around the nerve, which limits its use in
acute inflammatory situations frequently encountered on
the ICU. A novel, less invasive VNS method is transve-
nous VNS (tVNS).
Objective
To determine whether tVNS exerts anti-inflammatory
effects during experimental human endotoxemia.
Methods
A parallel randomized double-blind sham-controlled
study in healthy male volunteers was performed. Sub-
jects were randomized to receive either tVNS (n = 10)
or sham tVNS (n = 10).
In both groups, a stimulation catheter with multiple
circular electrode pairs was inserted in the left internal
jugular vein at C5-C7 spinal level to be situated adjacent
to the vagal nerve. In the tVNS group, stimulation
(0-10 V, 1 ms, 20 Hz) was continuously performed dur-
ing 30 minutes, starting 10 minutes before intravenous
administration of 2 ng/kg E. Coli LPS. In sham subjects,
the exact same procedures were performed, but the sti-
mulator was not switched on by an unblinded team
member.
Results
In all 20 subjects placement of the stimulation electrode
was successful and uneventful. Furthermore, in all sub-
jects of the tVNS group, laryngeal vibration was con-
firmed by an unblinded team member, indicating
stimulation of vagal fibers. LPS administration resulted in
an increase in heart rate of 26 ± 3 bpm and a decrease in
mean arterial pressure of 16 ± 2 mmHg, as well as fever
(increase of 1.5 ± 0.1 oC) and flu-like symptoms. No dif-
ferences between groups were observed. Furthermore,
plasma levels of inflammatory cytokines increased shar-
ply, but responses were similar between groups (Figure 1).
Likewise, cytokine production by leukocytes ex vivo resti-
mulated with LPS as well as neutrophil phagocytosis
capacity were unaffected by tVNS. Finally, heart rate
variability analysis revealed that during (sham) stimula-
tion, the ratio between low frequency and high frequency
(HF) spectral power was significantly lower, and HF
power in normalized units significantly higher in the
tVNS group compared with the sham group, suggestive
of increased parasympathethic activity (Figure 2, p = 0.02
for both indices, unpaired Student’s t-test at T = 0).
However, when corrected for baseline differences, this
effect was no longer statistically significant (p = 0.35 for
both indices).
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Conclusions
Thirty-minute transvenous vagus nerve stimulation is
feasible and safe but does not modulate the innate
immune response in humans in vivo during experimen-
tal human endotoxemia.
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Figure 1 Plasma concentrations of inflammatory cytokines during
endotoxemia. Data are expressed as medians od 10 subjects per
group. Inserted bar graphs depict median interquartile range of area
under curve (AUC) of cytokines. P values calculated using Mann-
Whitney U-tests.
Figure 2 Heart rate variability parameters during endotoxemia. Left
panel: ratio between low frequency and high frequency power
(LF/HF). Right panel: high frequency power in normalized units
(HFnu). Data are expressed as mea SEM of 10 subjects per group.
LH/HF was log-transformed to attain normal distribution. Gray box
indicates period in which the (sham) stimulation took place.
P-values indicate differences between groups over time calculated
using repeated measures two-way analysis of variance (ANOVA,
interaction term). AU: arbitrary units.
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